Senores Pharmaceuticals Eyes Strong FY25-26 Growth, US Injectables Expansion
Moneylife Digital Team 16 July 2025
Senores Pharmaceuticals Ltd (Senores), a research-focused generics manufacturer, reported 86% jump in revenue in FY24-25, driven by robust sales in regulated and emerging markets, while it ramps...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback